Proton pump inhibitors inhibit phospho1 activity and matrix mineralisation in vitro

HIGHLIGHTS

  • who: Katherine A. Staines from the School of Pharmacy and Biomolecular Sciences, University of Brighton, Lewes Road, Brighton , GJ, UK have published the Article: Proton Pump Inhibitors Inhibit PHOSPHO1 Activity and Matrix Mineralisation In Vitro, in the Journal: (JOURNAL)
  • what: In contrast the histamine-2 receptor antagonists (H2RA) nizatidine famotidine cimetidine and ranitidine had no inhibitory effects on the experiments show for the first time that PPIs and mineralisation in vitro revealing a potential mechanism by which these widely used drugs are associated with the risk of fractures. Similarly, here the authors show for the . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?